1. Home
  2. TECH vs COO Comparison

TECH vs COO Comparison

Compare TECH & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$72.40

Market Cap

11.4B

Sector

Health Care

ML Signal

N/A

Logo The Cooper Companies Inc.

COO

The Cooper Companies Inc.

N/A

Current Price

$57.41

Market Cap

13.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TECH
COO
Founded
1976
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
13.6B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
TECH
COO
Price
$72.40
$57.41
Analyst Decision
Hold
Hold
Analyst Count
13
16
Target Price
★ $70.50
$66.21
AVG Volume (30 Days)
2.6M
★ 4.7M
Earning Date
11-04-2026
09-09-2026
Dividend Yield
★ 0.44%
N/A
EPS Growth
★ 152.17
N/A
EPS
1.16
★ 2.49
Revenue
$1,215,039,000.00
★ $2,532,800,000.00
Revenue This Year
$4.34
$3.58
Revenue Next Year
$9.79
$4.07
P/E Ratio
$62.40
★ $22.69
Revenue Growth
N/A
★ 18.41
52 Week Low
$43.20
$51.01
52 Week High
$72.69
$89.83

Technical Indicators

Market Signals
Indicator
TECH
COO
Relative Strength Index (RSI) 56.02 34.88
Support Level $72.11 $51.01
Resistance Level $72.66 $73.39
Average True Range (ATR) 0.16 1.48
MACD -0.05 0.63
Stochastic Oscillator 48.08 82.68

Price Performance

Historical Comparison
TECH
COO

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About COO The Cooper Companies Inc.

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Share on Social Networks: